534 NB-UVB therapy response of different body regions in vitiligo
نویسندگان
چکیده
Narrow-Band Ultraviolet B (NB-UVB) in combination with topical therapy is a widely used treatment for non-segmental vitiligo (NSV). The location of the lesions influence on potential repigmentation response after therapy. To date however, these differences therapeutic between specific anatomical areas body have not been fully characterized. This study aimed to evaluate clinical NB-UVB 19 different regions. A multicentre NSV patients starting was performed hospitals Egypt, Singapore and Netherlands. Evaluation depigmented surface area regions conducted VES at baseline 6 months total 101 completed study. highest found lower facial region, followed by upper region trunk (> 75% 58%, 48% 46% patients, respectively). face showed significant better than face. lowest rates (<25% repigmentation) were observed feet (81%), hands (68%). Left-right dorsal-ventral sides demonstrated no repigmentation. In addition, torso limbs similar treatment. first compare We that BSA can be classified into 4 composite prognosis treatment, i.e. face; torso&limbs; axillae; hands&feet, from repigmentation, respectively. These results may direct use clinicians as it provides more detailed information per region.
منابع مشابه
Trichloroacetic Acid Peel 15% + NB-UVB Versus Trichloroacetic Acid Peel 25% + NB-UVB for Stable Non-Segmental Vitiligo
Apart from the famously known Koebner's phenomenon in vitiligo patients (development of isomorphic lesions at traumatized uninvolved skin of patients with cutaneous diseases), [2] it is widely known that there is wound-associated pigmentation in normal individuals. The latter could be explained by two major processes; the first is incontinentia pigmenti, which occurs after destroying the basal ...
متن کاملA Comparison of NB-UVB and PUVA in the Treatment of Vitiligo
Vitiligo is an acquired, progressive depigmenting disorder of the skin and mucous membranes in which melanocytes in affected skin are selectively destroyed. Theories regarding the mechanism of melanocyte destruction include autoimmune, cytotoxic, oxidative, and neural mechanisms. Vitiligo affects 0.5-2% of the world's population and the usual age of onset is in the third decade of life. Photoch...
متن کاملRandomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
OBJECTIVE To compare the efficacy of oral psoralen-UV-A (PUVA) with that of narrowband-UV-B (NB-UVB) phototherapy in patients with nonsegmental vitiligo. DESIGN Double-blind randomized study. SETTING Phototherapy unit in a university hospital. PATIENTS Fifty-six patients with nonsegmental vitiligo. Interventions Twice-weekly therapy with PUVA or NB-UVB. MAIN OUTCOME MEASURES The change ...
متن کاملa comparison between the efficacy of narrow band ultra violet b phototherapy with and without needling of the lesion in the treatment of vitiligo
normal 0 false false false en-us x-none ar-sa microsoftinternetexplorer4 background : vitiligo as a common pigmentary disorder affects up to 2% of the general population. there are several treatment modalities in the literature but photo therapy is one of the best known with an improving effect. the goal of this study was to compare the efficacy of nb-uvb alone with adjunction of nb-uvb with ne...
متن کاملTreatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy.
BACKGROUND Only a few clinical trials have been performed on the treatment of generalized vitiligo in children. Recently, narrow-band UVB therapy has been reported to be an effective and safe therapeutic option in adult patients with vitiligo. OBJECTIVE We studied the efficacy and safety of UVB (311 nm) therapy in children with generalized vitiligo and evaluated the effect of the therapy on t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Investigative Dermatology
سال: 2022
ISSN: ['1523-1747', '0022-202X']
DOI: https://doi.org/10.1016/j.jid.2022.09.549